StocksMediumUpdated•Originally published 8 October 2026•Updated 20 October 2026•
1 min read
Nexalin Technology Regains Nasdaq Listing Compliance
Key Facts
1Nexalin Technology announced it has regained compliance with Nasdaq's minimum bid price requirement.
2The Nasdaq Hearings Panel granted the company's request for continued listing of its shares.
Nexalin Technology announced it has regained compliance with Nasdaq's minimum bid price requirement. The company stated via GlobeNewswire that the Nasdaq Hearings Panel granted its request for continued listing of its shares, effectively removing the immediate threat of delisting.
NXL closed at $4.32 on October 7, 2026, with the stock trading between a day low of $4.31 and a high of $4.76 during that session. This regulatory milestone follows the company's efforts to maintain its listing status while advancing its clinical programs and commercial revenue objectives.